Ascendis Pharma A/S
ASND
Classement en actions
#1496
Ascendis Pharma A/S is a biopharmaceutical enterprise dedicated to advancing... Ascendis Pharma A/S is a biopharmaceutical enterprise dedicated to advancing therapeutic solutions for critical medical conditions that currently lack effective treatments. Its commercialized offering is SKYTROFA, a therapy prescribed for individuals suffering from growth hormone deficiency (GHD). The company boasts a robust development pipeline, featuring several TransCon-branded candidates. These include TransCon Growth Hormone (hGH), which is being progressed for pediatric GHD patients in Japan and for adults with GHD. Also under development are TransCon parathyroid hormone for adults with hypoparathyroidism, and TransCon CNP, aimed at treating pediatric achondroplasia. Further expanding its innovative portfolio, Ascendis is also developing a TransCon toll-like receptor (TLR) 7/8 agonist for intratumoral administration, alongside TransCon IL-2 ß/g, designed for systemic delivery. Founded in 2006, this enterprise maintains its corporate headquarters in Hellerup, Denmark.
Prix de l'action
$234.15
Dernière synchronisation: 2026-10-20
Capitalisation boursière
$14.61B
Changement (1 jour)
1.82%
Changement (1 an)
16.73%
Pays
DK
Échange Ascendis Pharma A/S (ASND)
Catégorie
Healthcare
Nombre d'actions en circulation pour Ascendis Pharma A/S (ASND)
Nombre d'actions en circulation au June 2026: 64.34M
Selon les derniers rapports financiers et le cours de l'action de Ascendis Pharma A/S, le nombre actuel d'actions en circulation est de 64.34M. À la fin de December 2024, l'entreprise avait 57.89M actions en circulation. Le nombre d'actions en circulation est généralement affecté par les divisions d'actions et les rachats d'actions.
Historique des actions en circulation de Ascendis Pharma A/S (ASND) de 2012 à 2026
Actions en circulation à la fin de chaque année
| Année | Actions en circulation | Changez |
|---|---|---|
| 2026 (TTM) | 64.34M | 6.17% |
| 2025 | 60.61M | 4.69% |
| 2024 | 57.89M | 2.85% |
| 2023 | 56.29M | 0.38% |
| 2022 | 56.07M | 2.37% |
| 2021 | 54.77M | 8.21% |
| 2020 | 50.62M | 8.84% |
| 2019 | 46.51M | 13.20% |
| 2018 | 41.09M | 22.18% |
| 2017 | 33.63M | 26.58% |
| 2016 | 26.56M | 12.16% |
| 2015 | 23.68M | 39.85% |
| 2014 | 16.94M | 56.78% |
| 2013 | 10.80M | 0.00% |
| 2012 | 10.80M | 0.00% |
Actions en circulation pour des entreprises similaires ou concurrentes
| Entreprise | Actions en circulation | Différence | Pays |
|---|---|---|---|
| 253.90M | 294.59% |
US
|
|
| 396.00M | 515.43% |
US
|
|
| 478.91M | 644.29% |
AU
|
|
| - | - |
CH
|
|
| 62.19M | -3.36% |
NL
|
